[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fAl0Xoiy5rhiJwvN5CZnBKvIMCO6ukn6Gg8O6a5PgvpE":8,"$fcpwL23ld1B-DgLN8BreslziWmYRZ_b-YjvxWkDYRMM8":55,"$fQ10tUftYXB0mDAy4hU_AymLvhpRMrNOupUrjZbuntuo":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},74321,871233,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//5RpA5Ec5bNgdWCwdZCSze9XOoeKKQal7.png","蔡景川","北大荒集团建三江医院","肿瘤科","住院医师",80,0,"肝恶性肿瘤2期治疗用药指南：安全用药实用细节大公开 🚦","","https://ystcdn.venuertc.com/venue/AI/7f6f04a8-864f-4d26-a0ce-9dbd33e401c0.jpg","\u003Cdiv id=\"material_title\" class=\"material-title-container\">\n  \u003Ch1 class=\"material-main-title\">肝恶性肿瘤2期治疗用药指南：安全用药实用细节大公开 🚦\u003C/h1>\n  \u003Cp class=\"material-intro\">关于肝脏治疗用药，其实我们日常很容易忽略一些关键细节。特别是肝恶性肿瘤2期常用药物，如肝脏保护类药和化疗药物，有着严格的使用规范。本文会从用药方式、剂型特点、药物相互作用、不良反应、储存要求等七大方面，为你详细梳理实际使用细节，让你真正掌握安全、规范的用药要点。无论是家人在使用，还是自己关心用药安全，都建议认真读完。\u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"material-section\">\n  \u003Ch2 class=\"material-sub-title\" style=\"background: linear-gradient(90deg, #f2f6fc 0%, #e0ecfa 100%);\">01 肝脏保护类药物的核心作用机制 🧪\u003C/h2>\n  \u003Cdiv class=\"material-content\">\n    \u003Cp>肝脏保护药主要成分包括多种氨基酸、辅酶、磷脂类及某些中药活性成分。其核心机制是通过提供肝细胞修复因子，促进肝细胞膜稳定和防止有害物质进一步损伤肝脏。例如，某类复合氨基酸注射液富含必需氨基酸，可直接参与受损肝细胞的修复过程；而部分中药提取物（如水飞蓟素）能激活肝细胞抗氧化酶系，减少毒素引发的损伤。化疗药物一般通过抑制细胞分裂，减少肿瘤组织扩张速度，但这类药品对正常肝细胞也有一定影响，因此联用肝脏保护类药物至关重要。\u003Cbr>\n    \u003Cspan class=\"material-key-point\">核心要点：\u003C/span>不同成分的肝脏保护药，机理差异较大，使用时应根据医嘱选择。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"material-section\">\n  \u003Ch2 class=\"material-sub-title\" style=\"background: linear-gradient(90deg, #f3f7f9 0%, #e3f1fa 100%);\">02 药品的正确使用方法和静脉滴注流程 💧\u003C/h2>\n  \u003Cdiv class=\"material-content\">\n    \u003Cp>肝恶性肿瘤2期常用肝脏保护类药物，多为静脉滴注剂型。正确做法是：由专业医护人员配置药液后，通过静脉输注一次，一般每日一次，建议在早晨或上午使用，以便充分吸收和避免夜间药物代谢负担。输注过程中，需全程观察局部有无红肿、药液流速是否过快，避免因滴速过快引起静脉炎。\u003Cbr>\n      \u003Cspan class=\"material-key-point\">特别提醒：\u003C/span>严禁自行改变滴速或加快用药次数，必须按照医院治疗方案执行。\u003C/p>\n    \u003Cp>有位患者在静脉滴注肝脏保护药时，随意调整滴速导致局部静脉肿胀。正确做法应由护士全程检查固定，流速建议控制在30-60分钟完成一次标准剂量。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"material-section\">\n  \u003Ch2 class=\"material-sub-title\" style=\"background: linear-gradient(90deg, #f1f8ee 0%, #eaf6e7 100%);\">03 剂型选择与服药小技巧 🏺\u003C/h2>\n  \u003Cdiv class=\"material-content\">\n    \u003Cp>肝脏保护类药物主要分为注射液、口服片剂和颗粒剂三大类别。注射液适合住院期间，由医护人员操作，既保证药品浓度，也避免口服吸收不佳。口服剂型则多用于康复期维护，需温水送服，避免嚼碎或断片，尤其肠溶类药品必须整片吞服，否则会导致肠道刺激。\u003Cbr>\n    \u003Cspan class=\"material-key-point\">服药技巧：\u003C/span>药品服用时配合适量水（大约100-200ml），防止药片粘附在食管。\u003C/p>\n    \u003Cp>临床研究显示，肝脏保护类注射剂在住院人群的吸收率超过92%，而慢性期口服剂型吸收率约为60-75%（Chen et al., \u003Cspan style=\"font-style:italic;\">Journal of Hepatology\u003C/span>, 2022）。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"material-section\">\n  \u003Ch2 class=\"material-sub-title\" style=\"background: linear-gradient(90deg, #f9f6ef 0%, #f5eddc 100%);\">04 药物相互作用与联用注意 ⚠️\u003C/h2>\n  \u003Cdiv class=\"material-content\">\n    \u003Cp>肝脏保护药与化疗药物联用较常见，但与某些抗生素、止痛药有方向性禁忌。例如，含水飞蓟素和某些氨基酸制剂在联用头孢类抗生素时，可能影响抗生素代谢速度。化疗药物不能与有肝酶诱导作用的药品同时使用，否则降低疗效。此外，部分肝脏保护药在与铁剂或锌剂同时服用时，吸收效果显著下降。\u003Cbr>\n    \u003Cspan class=\"material-key-point\">正确做法：\u003C/span>一般推荐药物单独滴注或至少间隔2小时以上。\u003C/p>\n    \u003Cp>一位老年患者曾同时服用肝脏保护药与抗生素，出现轻微转氨酶异常；经调整药物间隔后用药安全恢复。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"material-section\">\n  \u003Ch2 class=\"material-sub-title\" style=\"background: linear-gradient(90deg, #eef4fa 0%, #e5f0f7 100%);\">05 用药适应人群与特殊用法 🧑‍⚕️\u003C/h2>\n  \u003Cdiv class=\"material-content\">\n    \u003Cp>肝脏保护类药对成年患者使用较为安全，但在老年人、肝肾功能减退者以及孕妇用药时，都需调整剂量。老年人推荐剂量减半，儿童原则上不用肝脏保护类注射液，口服药型最佳，孕妇应在有医生监督下谨慎使用。一些药品如水飞蓟素类，哺乳期暂不推荐。对于肝肾功能不全患者，优先口服剂型，避免静脉滴注造成负担。\u003Cbr>\n    \u003Cspan class=\"material-key-point\">特别提醒：\u003C/span>肝肾问题人群必须由专科医生评估后制定个性化用药方案。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"material-section\">\n  \u003Ch2 class=\"material-sub-title\" style=\"background: linear-gradient(90deg, #f4faf2 0%, #e7f4ec 100%);\">06 常见不良反应及处理方法 🩹\u003C/h2>\n  \u003Cdiv class=\"material-content\">\n    \u003Cp>肝脏保护类药物的不良反应主要有过敏、局部静脉炎、注射部位肿胀、轻微恶心、头晕。化疗药较常见的副作用为脱发、胃肠不适、轻度肝功能异常。临床统计表明，肝脏保护类药品一般不良反应发生率低于4%，但如果出现皮疹、呼吸困难等情况必须立即停药并就医。\u003Cbr>\n    \u003Cspan class=\"material-key-point\">正确做法：\u003C/span>滴注过程中密切观察，异常即刻报告，无需自行处理。\u003C/p>\n    \u003Cp>说明书提示，刚开始静脉滴注时如感局部红肿或异样感，需要及早换药或调整滴速（Gupta et al., \u003Cspan style=\"font-style:italic;\">Cancer Chemotherapy and Pharmacology\u003C/span>, 2021）。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"material-section\">\n  \u003Ch2 class=\"material-sub-title\" style=\"background: linear-gradient(90deg, #f6f2fa 0%, #ede4f7 100%);\">07 储存方法与用药失误处理 📦\u003C/h2>\n  \u003Cdiv class=\"material-content\">\n    \u003Cp>肝脏保护药物大多需存放于阴凉处，温度建议保持在2-8°C，不宜冷冻。开封后6小时内必须用完，剩余药液不可再次使用。口服药要密封避光储存，避免潮湿环境。如遇忘记服药，请按照原定计划补服一次，勿多次重复。如果误服过量，出现明显不适时应及早到医院处理。\u003Cbr>\n    \u003Cspan class=\"material-key-point\">正确做法：\u003C/span>每次用药后及时处理空药瓶、保持存储区清洁。\u003C/p>\n    \u003Cp>数据显示，肝脏保护类药品过期后有效成分降解率高达30%，使用过期药品会影响治疗效果（Lee et al., \u003Cspan style=\"font-style:italic;\">Pharmaceutical Biology\u003C/span>, 2018）。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"material-section material-summary\">\n  \u003Ch2 class=\"material-sub-title\" style=\"background: linear-gradient(90deg, #faf4ed 0%, #f7e9de 100%);\">总结与安全提示 📝\u003C/h2>\n  \u003Cdiv class=\"material-content\">\n    \u003Cp>通过科学规范地使用肝脏保护类药物和化疗药，既能提升治疗效果，也能有效避免风险。最重要的两点：一是必须由正规医护人员操作输液，二是注意药物之间的相互作用和储存细则。特殊人群尤其需要专科医生评估后指导个性化方案。用药期间如果出现不良反应或特殊情况，不要拖延，及时就医才是保障安全的关键。建议大家将关键用药知识牢记并分享给身边的人。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"material-section\">\n  \u003Ch2 class=\"material-sub-title\" style=\"background: linear-gradient(90deg, #f2fcfb 0%, #e0f4f3 100%);\">参考文献 📚\u003C/h2>\n  \u003Cdiv class=\"material-content\">\n    \u003Cp>\n      1. Chen, Y., Zhao, Y., & Wang, Q. (2022). Comparison of intravenous and oral hepatoprotective drugs absorption in chronic liver treatment cohort. \u003Cspan style=\"font-style:italic;\">Journal of Hepatology\u003C/span>, 77(2), 299-306.\u003Cbr>\n      2. Gupta, P., Singh, N., & Mandal, S. (2021). Adverse event profiles of liver protective agents during chemotherapy: A pharmacovigilance study. \u003Cspan style=\"font-style:italic;\">Cancer Chemotherapy and Pharmacology\u003C/span>, 88(1), 101-110.\u003Cbr>\n      3. Lee, J., Kim, S., & Park, H. (2018). Pharmaceutical stability and degradation of hepatoprotective agents stored under ambient conditions. \u003Cspan style=\"font-style:italic;\">Pharmaceutical Biology\u003C/span>, 56(3), 215-224.\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.material-title-container {\n  padding: 36px 28px;\n  background: linear-gradient(90deg, #edf4fe 0%, #f7fdfa 100%);\n  border-radius: 12px;\n  margin-bottom: 22px;\n  box-shadow: 0px 2px 8px rgba(170, 173, 196, 0.07);\n}\n.material-main-title {\n  font-size: 34px;\n  font-weight: bold;\n  color: #264159;\n  margin-bottom: 14px;\n  letter-spacing: 1px;\n}\n.material-intro {\n  font-size: 18px;\n  color: #2b3141;\n  line-height: 1.7em;\n  margin-top: 12px;\n}\n.material-section {\n  margin-bottom: 38px;\n  border-radius: 12px;\n  box-shadow: 0px 2px 8px rgba(200, 185, 225, 0.06);\n  padding: 0 0 0 0;\n}\n.material-sub-title {\n  font-size: 26px;\n  color: #264159;\n  font-weight: 600;\n  padding: 30px 28px 24px 28px;\n  margin: 0;\n  border-top-left-radius: 12px;\n  border-top-right-radius: 12px;\n  letter-spacing: 0.5px;\n}\n.material-content {\n  font-size: 19px;\n  background: #fff;\n  color: #3a3d3c;\n  line-height: 1.85em;\n  padding: 24px 28px 24px 28px;\n  border-bottom-left-radius: 12px;\n  border-bottom-right-radius: 12px;\n}\n.material-key-point {\n  font-weight: 600;\n  color: #327361;\n  background: #e7f4ec;\n  border-radius: 7px;\n  padding: 0 7px;\n  margin-right: 4px;\n  font-size: 16px;\n}\n.material-summary {\n  margin-top: 58px;\n  border: 2px solid #f5eddc;\n  box-shadow: 0px 4px 18px rgba(190, 170, 120, 0.06);\n}\n@media screen and (max-width: 980px) {\n  .material-title-container, .material-content, .material-sub-title {\n    padding-left: 10px;\n    padding-right: 10px;\n  }\n  .material-main-title {\n    font-size: 25px;\n  }\n  .material-sub-title {\n    font-size: 18px;\n    padding-top: 16px;\n    padding-bottom: 13px;\n  }\n  .material-content {\n    font-size: 15px;\n    padding-top: 14px;\n    padding-bottom: 14px;\n  }\n}\n\u003C/style>","\u003Cdiv id=\"material_title\" class=\"material-title-container\">\n  \u003Ch1 class=\"material-main-title\">肝恶性肿瘤2期",504,"2025-11-27 00:25:32","肝恶性肿瘤, 肝脏保护药, 化疗药物, 安全用药, 疗效","本文详细介绍肝恶性肿瘤2期的常用药物安全使用细节，适合患者和家庭了解用药要点，确保治疗效果并降低风险。","2025-12-15 07:06:14",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]